The cadmium resistance system of Staphylococcus aureus plasmid pI258 was identified by Novick and Roth (9) and subsequently mapped by deletion analysis (8) . The cadA system results in reduced net uptake of Cd 2ϩ because of increased energy-dependent efflux of the toxic cation (22) . Cloning and DNA sequence analysis identified two genes called cadC and cadA (10) . The cadA gene product is a P-type ATPase, a member of the large family of related cation transport ATPases found in plant and animal cells as well as in microbes (16, 17) . The CadA ATPase protein itself is sufficient for resistance and decreased cadmium uptake in Bacillus subtilis cells (10) and for ATP-dependent Cd 2ϩ uptake by inside-out subcellular membranes (21) , equivalent to efflux by intact cells. The CadA ATPase can be labelled with 32 P from [ 32 P]ATP (20) , the characteristic of P-type ATPases that distinguishes them from other classes of membrane transport ATPases.
While the properties of CadA satisfactorily explain cadmium resistance, the role of cadC and the nature of the trans-acting component of the carefully regulated CadA system (3, 25) remain unclear. The cadC gene is involved in full cadmium resistance; cadC can be provided in trans and need not be present on the same plasmid as cadA (26) . The inducible nature of transcription was established, and the initiation site for cad mRNA synthesis was identified by reverse transcriptase primer extension (25) to a position 28 nucleotides upstream of the ATG start codon of the cadC gene (Fig. 1) . Operon-length mRNA of 2.6 kb, including both cadC and cadA, was identified by Northern blot DNA-RNA hybridization (25) . Canonical Ϫ10 and Ϫ35 Escherichia coli-like RNA polymerase recognition sites ( Fig. 1) were identified in the sequence (25) . A 7-nucleotide inverted repeat segment, including the first nucleotides transcribed into mRNA, was proposed as the operator site for binding of a then-elusive trans-acting DNA-binding regulatory protein (25) .
Cation-inducible gene function was studied by measurements of Cd 2ϩ efflux by whole cells (25) and subcellular membranes (21) and through induction of the reporter genes ␤-lactamase (25) and luciferase (3). However, the presumed transacting regulatory protein was not identified (25) . Because of the need for cadC in gene regulation (21) and the sequence homologies (1, 26) among the predicted CadC protein product, the ArsR regulatory protein (12, 14, 15, 23) for the arsenic resistance system, and the SmtB regulatory protein for cyanobacterial metallothionein synthesis (6), we undertook a direct test of the hypothesis that CadC is the regulatory protein for cadA operon transcription. By in vitro assays with CadC protein and the appropriate operator/promoter DNA, CadC has been shown to be a DNA-binding, negatively acting regulatory protein.
MATERIALS AND METHODS
Abbreviations. DTT, dithiothreitol; IPTG, isopropyl-␤-D-thiogalactopyranoside; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Bacterial strains and plasmids. E. coli HB101 (13) and plasmid pTrc99A (Pharmacia-LKB, Piscataway, N.J.) were used. E. coli HB101(pSB100) was grown overnight in Luria-Bertani medium (13) containing 100 g of ampicillin per ml at 37ЊC and diluted 200-fold. After growth to a turbidity of about 60 Klett units, cells were induced with 1 mM IPTG and grown for 3 h. Cells were harvested by centrifugation, washed twice with TrisHCl buffer (20 mM Tris-HCl [pH 7.5], 5 mM ␤-mercaptoethanol). Cells from 1 liter of culture were suspended in 20 ml of Tris-EDTA buffer (13) and disrupted by sonication (20 s each time, with cooling on ice, until turbidity was completely deduced). Cell debris was removed by centrifugation at 20,000 rpm in an SS34 rotor in a Sorvall refrigerated centrifuge. The CadC protein present in this crude protein preparation was purified on a heparin-agarose column (2.6 by 10 cm) (type I, H5263; Sigma Chemical Company, St. Louis, Mo.) run on fluid pressure liquid chromatography (FPLC) (Pharmacia Biotech) and eluted with TMGB buffer (50 mM Tris-HCl [pH 7.6], 5 mM MgCl 2 , 5 mM ␤-mercaptoethanol, 100 g of glycerol per liter) on a gradient from 0.1 to 1 M NaCl at a rate of 5 ml/min. Four-milliliter fractions were collected, and protein was measured by Bio-Rad protein reagent assay at 595 nm with a spectrophotometer. Samples (5 l from each FPLC fraction) were subjected to 0.1% SDS-18% PAGE analysis as described in Results. The protein from fractions containing CadC protein was concentrated by ultrafiltration through an Amicon YM3 filter to 8 mg/ml and stored at Ϫ80ЊC prior to use.
Purified ArsR protein from the regulatory gene of the arsenic resistance operon of plasmid pI258 (4, 18) was used as a negative control for the specificity of CadC binding to DNA and was provided by Y. Chen (1a) .
PCR cloning of the 203-nucleotide fragment that includes the regulatoryregion DNA and the start of the cadC gene. The 200-nucleotide region from positions 573 through 772 of the published sequence (10) shown in Fig. 1 was amplified as a 203-nucleotide fragment, with AA at the 5Ј end and C at the 3Ј end added, by PCR with 25-mer oligomers AAGAATTCGTTTTTGAGACTAGA AT (with an EcoRI site at the 5Ј end) and TTGGATCCCCTTGTATTCGAT TAAC (with a BamHI site at the 5Ј end). After the PCR product was digested with restriction endonuclease EcoRI or EcoRI and BamHI, the PCR product was purified by agarose gel electrophoresis. This fragment was isolated by electroelution, extracted with phenol to remove proteins, and precipitated with ethanol. The purified PCR product was used directly as the substrate for 32 P labelling with [␣- Gel retardation assay. The 203-nucleotide cad operator/promoter DNA fragment, prepared as described above, was labelled at both ends by using [␣-32 P]dATP, a mixture of deoxynucleoside triphosphates, and DNA polymerase (Klenow fragment). Protein binding was measured by gel mobility shift assay (2, 12, 24) . CadC protein with added cations (as indicated) was added to buffer containing 10 mM Tris-HCl (pH 7.5), 1 mM Na 2 -EDTA, 0.1% Nonidet P-40, 50 mM KCl, 0.3 mM DTT, 4% (vol/vol) glycerol, 50 g of poly(dI-dC) (Boehringer GmbH, Mannheim, Germany) per ml, and 50 g of bovine serum albumin per ml and incubated for 10 min at room temperature. Then 32 P-labelled proposed cad operator/promoter DNA was added (for a total volume of 20 l), and incubation continued for 15 min before samples were subjected to gel electrophoresis on 5% polyacrylamide gels.
DNase I footprinting assay. DNase I footprinting assays were carried out as described by Wu and Rosen (24) in a buffer containing 10 mM Tris-HCl (pH 7.6), 0.1 M KCl, 10% glycerol, 0.2 mM Na 2 -EDTA, 0.2 mM DTT, 50 g of bovine serum albumin per ml, 50 g of poly(dI-dC) per ml, 32 P-labelled cad operator DNA, and CadC protein (as indicated) in a total volume of 20 l. The 203-nucleotide cad DNA fragment, prepared as described above, was digested with EcoRI endonuclease and labelled specifically at the EcoRI end with [␣-32 P]dATP and DNA polymerase (Klenow fragment). After 15 min at room temperature, 0.04 U of DNase I (Boehringer GmbH) was added in 30 l of buffer containing 25 mM Tris-HCl (pH 7.6), 50 mM KCl, 5 mM MgCl 2 , 1.7 mM CaCl 2 , 83 g of bovine serum albumin per ml, and 0.2 mM DTT. After 45 s at 25ЊC, the reaction was terminated by adding 10 g of tRNA in 50 l of 20 mM Na 2 -EDTA solution. Proteins were extracted with phenol-chloroform, and DNA from the aqueous layer was precipitated with ethanol and redissolved in 7 l of formamide dye solution (0.05% xylene cyanol, 0.05% bromophenol blue, and 1 mM Na 2 -EDTA [pH 8.0] in deionized formamide). After being denatured by heating at 75ЊC for 5 min, DNA was analyzed on a sequencing gel.
Runoff in vitro transcription. Assays were adapted from reference 27 and the Promega transcription kit instructions with RNA polymerase (E. coli) from Pharmacia Biotech. Unless specified, cad operator/promoter DNA was added to polymerase buffer containing CadC protein (and cations as indicated). RNA polymerase was added, and after 15 min at 38ЊC, the reaction was started by adding 4 l of a mixture containing (per reaction) 2 Ci of [␣-32 P]UTP, 0.17 mM nonradioactive UTP, and 2.5 mM (each) ATP, CTP, and GTP. After incubation at 38ЊC for 20 min and phenol-chloroform extraction, nucleic acids in the aqueous layer were precipitated with ethanol, dissolved, and loaded and electrophoresed on a 4% polyacrylamide sequencing gel.
RESULTS

Overproduction of the CadC protein.
The cadC gene of S. aureus pI258 was cloned into an E. coli expression vector plasmid (see Materials and Methods) for overproduction of the CadC protein. A protein band of appropriate size (13.5 kDa) was seen by SDS-PAGE gel analysis after induction by IPTG (data not shown). The protein was found primarily in the soluble fraction after sonication, and inclusion bodies of denatured CadC protein were not made under these conditions. After partial purification by heparin-agarose column chromatography, the CadC protein was found in fractions 20 to 23 (Fig. 2) . CadC was estimated to be approximately 70% pure by scanning photographs of the Coomassie blue-stained protein gel (Fig. 2) . The protein from fractions 19 through 23 was concentrated by ultrafiltration (see Materials and Methods) and rechromatographed on gel filtration (Sephadex G-75; Sigma Chemical Company) or cation-exchange (S Sepharose, S-1264; Sigma Chemical Company) columns. Purification was not achieved by these chromatographic steps (data not shown), and so protein from heparin-agarose gel chromatography was used without further purification in the experiments discussed below. Efforts to purify CadC to homogeneity continue (7a). Until protein-DNA association assays are confirmed with purified CadC protein, the possibility remains that some of the results reported here are due to contaminating E. coli proteins in CadC preparations.
CadC protein-DNA association measured by gel retardation assay. As shown in Fig. 3 , binding of the CadC protein to the proposed operator/promoter region of cad operon DNA resulted in a shift of cad DNA to two more slowly migrating positions during gel electrophoresis. In subsequent experiments, the titration of operator/promoter DNA with CadC protein was quantitated with an AMBIS radioactivity scanner (Fig. 4 and 5) . Both retarded forms became measurable at CadC protein levels greater than 1 nM (Fig. 4) . (Calculations were based on the estimated 70% purity of the CadC protein (Fig. 6) and on the assumption that all protein was added as an active 13,500-Da monomer.) Retarded bands of forms 1 and 2 appeared concurrently, and there was no concentration range of CadC protein that formed only bound form 1 (Fig. 4) . At lower ratios of CadC to DNA, form 1 predominated (Fig. 3 , lane 3, and Fig. 4) ; at higher ratios of CadC to DNA, form 2 was more abundant. A half-binding constant of 5 nM CadC for this association was estimated with 0.37 nM DNA present (Fig. 4 ). An important control for the specificity of gel retardation was that the addition of 200-fold excess nonradioactive operator/ promoter DNA (Fig. 3, lane 7 ) resulted in displacement of protein from 60% of the radioactive DNA. With a different operator/promoter DNA (from the ars operon of plasmid pI258 [4] ), the addition of CadC protein did not result in a significant shift in mobility of DNA on the gel (Fig. 3, lane 9) . With specific gel retardation of the cad operator/promoter DNA by CadC protein determined, the effects of added cations on the release of CadC from DNA were then measured. The addition of high concentrations of Cd 2ϩ , above 50 M, caused a decrease in the amount of retarded form 2 and an increase in the amount of retarded form 1 (Fig. 5A) . Free unretarded DNA also appeared as increasing levels of Cd 2ϩ were added. However, even with 5 mM Cd 2ϩ in vitro, only half of the DNA was free form (Fig. 5A) . It is possible that the CadC protein is not released from DNA by the addition of cations. The inability to obtain complete release of regulatory proteins from DNA in vitro at cation concentrations expected to be functioning in vivo has been found with other systems; for example, high levels of arsenite are required to partially displace the ArsR regulatory protein from ars operon DNA (12, 24) . The buffer used in gel retardation experiments includes 1 mM EDTA and 0. , and Mn 2ϩ had no effect under the same conditions (data not shown).
CadC DNA binding site. DNase I footprinting assays with radioactive cad operator/promoter DNA showed a protected region approximately from nucleotides 669 to 689 (according to the numbering system of Nucifora et al. [10] ), corresponding to positions Ϫ7 to ϩ14 (Fig. 1 and 6 ) relative to the in vivo initiation site for mRNA synthesis (25) . A second location for protection by CadC protein occurred approximately at positions 645 to 648 (Fig. 6) , in the region predicted for RNA polymerase binding (Fig. 1) . Both regions became protected at about the same concentration of CadC protein (Fig. 6) . Current experiments do not allow the determination of whether binding to the transcription initiation site corresponds to bound form 1 of gel retardation experiments and whether additional upstream binding results in bound form 2 (Fig. 3) . Experiments with mutant and shortened operator/promoter DNAs will resolve this question. Fig. 3) , each containing 0.37 nM cadA DNA plus increasing amounts of CadC protein, were subjected to gel retardation electrophoresis, and the dried gel was analyzed on an AMBIS radioactivity scanner. The amounts of free DNA, the intermediate retarded form 1, and the slower retarded form 2 are indicated. 
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Runoff in vitro transcription. With purified cadC operator/ promoter DNA and RNA polymerase from E. coli, in vitro transcription and incorporation of 32 P-labelled ribonucleotides into mRNA (Fig. 7, lane 2) occurred from about the position previously determined in vivo (25) . The addition of CadC protein completely repressed in vitro transcription (Fig. 7, lane  3) . The addition of 10 M Cd 2ϩ did not relieve CadC repression of in vitro transcription ( Fig. 7 ; compare lanes 4 and 5), and Cd 2ϩ itself was inhibitory for overall transcription (Fig. 4,  compare lanes 2 and 4) . The addition of RNA polymerase before the addition of CadC protein allowed transcription to proceed, although not at the level for DNA without CadC protein (Fig. 7, lanes 6 and 7) .
In runoff transcription assays, gradually increasing CadC concentrations resulted in greater inhibition of mRNA synthesis (Fig. 8A) , with a CadC/DNA ratio of about 4:1 (mol/mol) (Fig. 8A, lane 3) . Specificity was shown in that purified ArsR repressor protein had no effect (data not shown). 
DISCUSSION
This is the first report of in vitro regulation of the cadA operon of S. aureus plasmid pI258, and it provides direct evidence that the CadC protein (10, 25, 26 ) is a trans-acting regulatory protein and functions as a repressor of transcription (Fig. 7) . The CadC protein bound specifically to the previously proposed cad operator DNA and was released by the addition of inducers Cd 2ϩ , Pb 2ϩ , and Bi 3ϩ ( Fig. 5 and 8B ). In DNase I footprinting experiments (Fig. 6) , CadC bound to DNA protected the predicted (25) inverted repeat operator region and an additional upstream region marked in Fig. 1 . The protection afforded by CadC from DNase I attack was also relieved by added Pb 2ϩ and Bi 3ϩ (data not shown). CadC protein repressed in vitro transcription from the cad promoter ( Fig. 7  and 8 ).
CadC is a member of a newly proposed family of DNAbinding regulatory proteins, predicted on the basis of sequence homologies (1, 15) to share functional characteristics. The other members of this family are ArsR (the regulatory protein for the arsenic resistance system [4, 12, 15, 23] ) and SmtB (the regulatory protein for cyanobacterial metallothionein synthesis [6] ). Bairoch (1) suggests that a helix-turn-helix motif is a recognizable candidate for the DNA binding region. With work just beginning on the interaction of CadC with operator/ promoter DNA, we look forward to experimental clarifications of the different actions of these somewhat similar heavy metal cation-responding trans-acting DNA-binding regulatory proteins.
The natures of the two forms of CadC protein associated with cad operator DNA (in gel retardation experiments) and the two regions of DNA protected in DNase I footprinting assays are also left for future experiments. However, it is tempting to hypothesize that CadC sits as a dimer on the inverted repeat region shown in Fig. 1 , forming retarded intermediate complex 1. Then the addition of a second dimer of CadC (to form a tetramer bound to DNA) might result in retarded form 2, with the additional protected region approximately from base pair 645 to base pair 648 (which occurs 20 bp, or two turns of the DNA helix, further upstream). We have not been able to separate these steps as a function of added CadC concentration (Fig. 4 and 6) . A mutational approach, such as disrupting the 7-bp inverted repeat, extending the intradyad distance, or removing the upstream sequence from positions 645 to 648, will clarify the nature of this protein-DNA interaction.
CadC is expected to respond to very low intracellular concentrations of the toxic cation, as MerR responds to submicromolar mercury concentrations (11, 19) both in vivo and in vitro. CadC (Fig. 5) and ArsR (12, 24) in vitro respond poorly to added effector ions. The basis for this unexpected poor response is unknown. It may be that Cd 2ϩ does not cause complete dissociation of CadC from operator DNA (Fig. 5) but only an association sufficiently reduced so that RNA polymerase can proceed or displace CadC (Fig. 8B) .
Previous studies showed that expression of the cadmium resistance system is tightly regulated (3, 5, 20, 25, 26) , but the trans-acting regulatory protein was not identified. The vector plasmid used by Yoon et al. (25, 26) contained an unrecognized copy of the cadC gene, which precluded determination of the role of the cadC gene in reporter gene expression experiments (25) .
